United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - this intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. 0.9% sodium chloride injection usp is indicated for extracellular fluid replacement, treatment of metabolic alkalosis in the presence of fluid loss and mild sodium depletion. 0.9% sodium chloride injection usp is also indicated for use as a priming solution in hemodialysis procedures and may be used to initiate and terminate blood transfusions without hemolyzing red blood cells. sodium chloride injection usp is also indicated as a pharmaceutic aid and diluent for the infusion of compatible drug additives. refer to prescribing information accompanying additive drugs. this solution is contraindicated where the administration of sodium or chloride could be clinically detrimental. directions for use of plastic container caution: do not use plastic container in series connection. to open check for minute leaks by squeezing solution container firmly. if leaks are found, discard solut

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - these intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes and water for hydration. 0.9% sodium chloride injection usp is indicated for extracellular fluid replacement, treatment of metabolic alkalosis in the presence of fluid loss and mild sodium depletion. 0.9% sodium chloride injection usp is also indicated for use as a priming solution in hemodialysis procedures and may be used to initiate and terminate blood transfusions without hemolyzing red blood cells. 0.45% sodium chloride injection usp is primarily a hydrating solution and may be used to assess the status of the kidneys, since more water is provided than is required for excretion of salt. it may also be used in the treatment of hyperosmolar diabetes where the use of dextrose is inadvisable and there is a need for large amounts of fluid without an excess of sodium ions. sodium chloride injections usp are also indicated as pharmaceutic aids and diluents for the infusion of compatible drug additives.

United States - English - NLM (National Library of Medicine)

it3 medical llc - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698) - this intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. this product is designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. consult prescribing information for indications and usage  of drug additives to be administered in this manner. this solution is contraindicated where the administration of sodium or chloride could be clinically detrimental.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - this intravenous solution is indicated for use in adults and pediatric patients as sources of electrolytes and water for hydration. 0.9% sodium chloride injection usp is indicated for extracellular fluid replacement, treatment of metabolic alkalosis in the presence of fluid loss and mild sodium depletion. 0.9% sodium chloride injection usp is also indicated for use as a priming solution in hemodialysis procedures and may be used to initiate and terminate blood transfusions without hemolyzing red blood cells. 0.9% sodium chloride injection usp is also indicated as pharmaceutic aid and diluent for the infusion of compatible drug additives. refer to prescribing information accompanying additive drugs. this solution is contraindicated where the administration of sodium or chloride could be clinically detrimental.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - these intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes and water for hydration. 0.9% sodium chloride injection usp is indicated for extracellular fluid replacement, treatment of metabolic alkalosis in the presence of fluid loss and mild sodium depletion. 0.9% sodium chloride injection usp is also indicated for use as a priming solution in hemodialysis procedures and may be used to initiate and terminate blood transfusions without hemolyzing red blood cells. 0.45% sodium chloride injection usp is primarily a hydrating solution and may be used to assess the status of the kidneys, since more water is provided than is required for excretion of salt. it may also be used in the treatment of hyperosmolar diabetes where the use of dextrose is inadvisable and there is a need for large amounts of fluid without an excess of sodium ions. sodium chloride injections usp are also indicated as pharmaceutic aids and diluents for the infusion of compatible drug additives.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 70 g in 100 ml - this intravenous solution is indicated for use in adults and pediatric patients as a source of calories and water for hydration. solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products. administration of solutions containing hypertonic dextrose is contraindicated in patients with intracranial or intraspinal hemorrhage, diabetic coma or delirium tremens, especially if such patients are already dehydrated. there is no specific pediatric dose. the dose is dependent on weight, clinical condition, and laboratory results. follow recommendations of appropriate pediatric reference text. (see warnings and precautions .)

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - dextrose, unspecified form (unii: iy9xdz35w2) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose 5 g in 100 ml - these intravenous solutions are indicated for use in adults and pediatric patients as sources of calories and water for hydration. solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products. there is no specific pediatric dose. the dose is dependent on weight, clinical condition, and laboratory results. follow recommendations of appropriate pediatric reference text. (see warnings and precautions .)

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - 5% dextrose injection usp is indicated for use in adults and pediatric patients as sources of calories and water for hydration. this product is designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. consult prescribing information for indications and usage of drug additives to be administered in this manner. solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products. do not administer 5% dextrose injection usp simultaneously with blood through the same infusion set because hemolysis or pseudoagglutination may occur.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - dextrose (unii: iy9xdz35w2) (dextrose - unii:iy9xdz35w2) - 70% dextrose injection usp is indicated as a caloric component in a parenteral nutrition regimen. 70% dextrose injection usp is used with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: (1) the alimentary tract cannot or should not be used, (2) gastrointestinal absorption of protein is impaired, or (3) metabolic requirements for protein are substantially increased, as with extensive burns. the infusion of 70% dextrose injection usp  is contraindicated in patients having intracranial or intraspinal hemorrhage, in patients who are severely dehydrated, in patients who are anuric, and in patients in hepatic coma. solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products.

Egypt - English - EDA (Egyptian Drug Authority)

janssen cilag-switzerland - oral drops